|
|||||
       |
A developer of medical monitoring systems with data from wearable devices will soon start asking individuals with epilepsy to offer data for an algorithm that predicts seizures. . . . → Read More: Study to Provide Real World Data for A.I. Seizure Forecasts 
The U.S. government’s health preparedness agency awarded a contract with a university lab to explore organ models on chips to document effects of radiation sickness. . . . → Read More: Organ Chip Devices to Model for Radiation Sickness  Comments are closed  Finance, New products  biomedical, biotechnology, contract, engineering, entrepreneurs, FDA, life sciences, medical device, physical sciences, preclinical, university 
A group of managed care organizations is examining the value of real world data from Europe and the U.S. to help FDA review alternative biologic drugs. . . . → Read More: FDA Funds Study of Real World Data for Biosimilars Comments are closed Finance, Regulations biomedical, FDA, grant, health care, mathematics, pharmaceuticals, software 
The Food and Drug Administration authorized marketing of a genetic test for detecting hundreds of gene variants associated with a higher risk of developing certain cancers. . . . → Read More: FDA Clears Genetic Cancer Risk Detection Test One comment - (Comments are closed) New products, Regulations biomedical, biotechnology, cancer, FDA, genomics, life sciences, medical device 
A start-up biotechnology company says it received the okay for its investigational new drug application of an anti-viral drug to treat a whole class of seasonal flu strains. . . . → Read More: FDA Clears Biotech Seasonal Flu Treatment Trial Comments are closed New products, Regulations biomedical, biotechnology, clinical trials, entrepreneurs, FDA, licensing, life sciences, pharmaceuticals 
A new award from National Institutes of Health funds preclinical work to prepare for a clinical trial assessing a treatment to reverse brain signaling damage in people with Alzheimer’s disease. . . . → Read More: Small Biz Grant Supports Regenerative Alzheimer’s Treatment Comments are closed Finance, New products Australia, biomedical, chemistry, clinical trials, entrepreneurs, FDA, grant, life sciences, manufacturing, NIH, pharmaceuticals, physical sciences, preclinical 
A new company developing treatments for neurological and psychiatric diseases from aberrant immune system activity is raising $58 million in seed funds. . . . → Read More: Autoimmune Neuro Disease Start-Up Raises $58M One comment - (Comments are closed) Finance, New products biomedical, biotechnology, entrepreneurs, equity, FDA, investment, life sciences, pharmaceuticals, preclinical, psychiatric, venture capital 
The U.S. Food and Drug Administration issued new regulatory guidance for clinical trials of medical devices designed to prevent or treat opioid use disorder. . . . → Read More: FDA Issues Guidance for Opioid Therapy Device Trials Comments are closed Regulations biomedical, clinical trials, FDA, life sciences, medical device, psychiatric 
A biotechnology company creating living tissue from a person’s stem cells says it received FDA clearance for a clinical trial of its replacement knee cartilage. . . . → Read More: Trial Cleared for Lab-Grown Replacement Knee Cartilage Comments are closed New products, Regulations biomedical, biotechnology, chemistry, clinical trials, engineering, entrepreneurs, FDA, life sciences, pharmaceuticals, physical sciences, preclinical, stem cells, university 
A biotechnology company designing immunotherapies for solid tumor cancers with a patient’s white blood cells is raising $80 million in its initial public offering or IPO. . . . → Read More: Cancer Immunotherapy Biotech Issues $80M IPO Comments are closed Finance biomedical, biotechnology, cancer, clinical trials, equity, FDA, investment, IPO, licensing, pharmaceuticals, venture capital |
||||
|
Copyright © 2023 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts